financetom
Business
financetom
/
Business
/
Alcon Posts Q2 Revenue Miss on Softer Market Conditions, Earnings Beat on Lower Tax Rate, Needham Says
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Alcon Posts Q2 Revenue Miss on Softer Market Conditions, Earnings Beat on Lower Tax Rate, Needham Says
Aug 20, 2025 12:35 PM

03:03 PM EDT, 08/20/2025 (MT Newswires) -- Alcon ( ALC ) missed Q2 revenue consensus due to softer market conditions and reported earnings-per-share beat on lower tax rate, while its contact lens market share was likely up in the quarter, Needham said in a Wednesday note.

The eyecare company on late Tuesday posted Q2 revenue of $2.58 billion on core EPS of $0.76, versus respective estimates of $2.62 billion and $0.72 by analysts polled by FactSet.

Needham estimates Alcon's ( ALC ) contact lens market share in Q2 grew 50 basis points on an annual basis to 26.3%.

Alcon ( ALC ) lowered its 2025 revenue guidance to $10.3 billion to $10.4 billion from $10.4 billion to $10.5 billion due to lower market growth assumptions and reaffirmed its EPS guidance of $3.05 to $3.15 due to a more favorable tax assumption, Needham said.

Needham maintained its buy rating on the stock with a price target of $107.

Shares of Alcon ( ALC ) fell 9.5% in recent Wednesday trading.

Price: 81.58, Change: -8.54, Percent Change: -9.47

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Opko Health Insider Bought Shares Worth $347,820, According to a Recent SEC Filing
Opko Health Insider Bought Shares Worth $347,820, According to a Recent SEC Filing
Mar 17, 2025
05:33 PM EDT, 03/17/2025 (MT Newswires) -- Phillip Frost, 10% Owner, Director, CEO & Chairman, on March 17, 2025, executed a purchase for 200,000 shares in Opko Health ( OPK ) for $347,820. Following the Form 4 filing with the SEC, Frost has control over a total of 247,197,576 common shares of the company, with 3,568,951 shares held directly and...
Nanobiotix Amends Licensing Deal With Johnson & Johnson
Nanobiotix Amends Licensing Deal With Johnson & Johnson
Mar 17, 2025
05:32 PM EDT, 03/17/2025 (MT Newswires) -- Nanobiotix ( NBTX ) said late Monday it has amended a global licensing deal for JNJ-1900 with Johnson & Johnson's ( JNJ ) Janssen Pharmaceutica, extending its cash visibility. The amendment removed Nanobiotix's ( NBTX ) funding obligation for the NANORAY-312 trial, while releasing Johnson & Johnson ( JNJ ) from some potential...
Ramaco Resources to Pay Quarterly Dividend
Ramaco Resources to Pay Quarterly Dividend
Mar 17, 2025
05:43 PM EDT, 03/17/2025 (MT Newswires) -- Ramaco Resources ( METCB ) said late Monday it will pay a Q2 dividend of $0.06875 per share of Class A stock to shareholders of record on May 30. The dividends will be paid in Class B stock and issued on June 13, the company said. ...
Ryan Specialty Holdings Insider Sold Shares Worth $2,079,000, According to a Recent SEC Filing
Ryan Specialty Holdings Insider Sold Shares Worth $2,079,000, According to a Recent SEC Filing
Mar 17, 2025
05:44 PM EDT, 03/17/2025 (MT Newswires) -- Brendan Martin Mulshine, Executive Vice President & Chief Revenue Officer, on March 14, 2025, sold 30,000 shares in Ryan Specialty Holdings ( RYAN ) for $2,079,000. Following the Form 4 filing with the SEC, Mulshine has control over a total of 74,592 Class A common shares of the company, with 74,592 controlled indirectly....
Copyright 2023-2026 - www.financetom.com All Rights Reserved